Article History
Received: 16 April 2020
Accepted: 22 May 2020
First Online: 17 June 2020
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Several patents for conditional reprogramming technology has been awarded to Georgetown University by the United States Patent Office. The license for this technology has been given to Propagenix for commercialization. The inventor, X.L., and Georgetown University receive potential royalties and payments from Propagenix.
Free to read: This content has been made available to all.